TY - JOUR
T1 - Advancing mitochondria as a therapeutic agent
T2 - Advancing mitochondria as a therapeutic Agent
AU - Caicedo, Andrés
AU - Singh, Keshav K.
N1 - Copyright © 2023. Published by Elsevier B.V.
PY - 2023/3
Y1 - 2023/3
N2 - This article intends to provide an update of the needs in the field working in the artificial mitochondrial transfer/transplant (AMT/T), and an overview of the highlights from the articles in the special issue “Advances of Mitochondria as a therapeutic agent”. In the last 4 decades, scientists developed innovative therapeutic applications based on the AMT/T, inspired by the natural transfer of mitochondria between cells to repair cellular damage or treat diseases. The clinical application of AMT has become the priority for the field involving the replacement or augmentation of healthy mitochondria in the harmed tissue, especially in the treatment of organ ischemia–reperfusion injury. However, we remark in our article that key questions remain to be answered such which one is the best isolation protocol, tissue or cell source for isolation, and others of great importance to move the field forward.
AB - This article intends to provide an update of the needs in the field working in the artificial mitochondrial transfer/transplant (AMT/T), and an overview of the highlights from the articles in the special issue “Advances of Mitochondria as a therapeutic agent”. In the last 4 decades, scientists developed innovative therapeutic applications based on the AMT/T, inspired by the natural transfer of mitochondria between cells to repair cellular damage or treat diseases. The clinical application of AMT has become the priority for the field involving the replacement or augmentation of healthy mitochondria in the harmed tissue, especially in the treatment of organ ischemia–reperfusion injury. However, we remark in our article that key questions remain to be answered such which one is the best isolation protocol, tissue or cell source for isolation, and others of great importance to move the field forward.
KW - Humans
KW - Mitochondria
KW - Reperfusion Injury/therapy
UR - http://www.scopus.com/inward/record.url?scp=85146483961&partnerID=8YFLogxK
U2 - 10.1016/j.mito.2023.01.003
DO - 10.1016/j.mito.2023.01.003
M3 - Editorial
C2 - 36657505
AN - SCOPUS:85146483961
SN - 1567-7249
VL - 69
SP - 33
EP - 35
JO - Mitochondrion
JF - Mitochondrion
ER -